Onward and upward! 🚀 $CSDX #OTCQB #Audit #PCAOB #FinancialTransparency #GlobalGrowth

📢 SEC Filing Update — Form 3 Filed! CS Diagnostics Corp. (Ticker: CSDX) has filed multiple Initial Statements of Beneficial Ownership (Form 3) with the SEC, reporting insider holdings as of Dec 31, 2025. These filings reflect initial disclosures of beneficial ownership by key stakeholders under Section 16(a) of the Securities Exchange Act. $CSDX #SEC #Form3 #InsiderOwnership #EDGAR

🙏 Thank you @BriefGlanceNews for featuring CS Diagnostics (OTCQB: CSDX) and our exciting partnerships with UAE leaders Emirate Wet Wipes LLC and Gulf Centre Group to support the global launch of MEDUSA SDP. 🇦🇪🌍 These strategic manufacturing alliances mark a major step forward as we scale production and expand advanced hygiene solutions across the GCC, Europe, and beyond. Read the full article here: briefglance.com/articles/cs-… $CSDX #MEDUSA #HealthTech #GlobalExpansion #UAE #Partnerships

CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products globenewswire.com/news-relea… $CSDX @MedusaSdp

The Street Reports article 🪄 thestreetreports.com/medtech… $CSDX @ts_reports

🚀 CS Group | Commercial Scale & Global Expansion Update CS Group (OTCQB: CSDX) announces a multi-channel sales model, global logistics partnerships (DHL & FedEx), and a sustainable innovation roadmap supporting the rollout of MEDUSA SDP. 🔹 B2B: Hospitals, gyms, schools, corporate & industrial clients 🔹 B2C: Retail shelves (UAE & Germany), Amazon, Noon, EU e-commerce, DTC 🔹 Global fulfillment: DHL (bulk/institutional) | FedEx (consumer/retail) 🔹 Pipeline: Bio-degradable, dissolving MEDUSA wet wipes (regulatory prep underway) 📈 Translating innovation into commercially viable, globally relevant products. globenewswire.com/news-relea… 👉 medusa-sdp.com/en/ $CSDX @MedusaSdp #OTCQB #Uplisting #MedTech #HealthcareInnovation #ESG #GlobalExpansion #Biotech

Company profile verified and Management Certificate uploaded on OTC Markets. News coming up🪄 $CSDX

🚀 MEDUSA has arrived. Production is moving, first inventory expected Feb 2026. Sales kick off in UAE & Germany simultaneously, with additional markets to follow. Wet Wipes. Bottles. Take a peek at our wet wipes 👀 Big momentum ahead. 🔥 $CSDX #MEDUSA #2026

Happy NewYear for everyone, may 2026 be a year of unity, health, success and prosperity. $CSDX #NewYear2026

Wishing you a Christmas filled with clarity, growth, and meaningful partnerships. Thank you for being part of our journey. $CSDX #Christmas

🍁 Happy Thanksgiving from CSDX! 🍁 As we gather with loved ones and pause to reflect on the year, all of us at CSDX want to extend our heartfelt appreciation for your continued trust, collaboration, and support. To our shareholders, thank you for believing in our vision and fueling our progress. To our clients, thank you for choosing us and allowing us to be part of your success. To our suppliers and partners, thank you for your reliability, dedication, and partnership that help us bring our mission to life. This season reminds us that meaningful progress is never achieved alone. We are truly grateful to have you as part of our journey and community. Your contributions and confidence inspire us to keep innovating, improving, and building a future we can all be proud of.🧡 $CSDX #Thanksgiving #GratitudeRocks

🚀 CSDX Shareholder Update The CSDX team is pushing forward with strong momentum as we advance our Reg D 506(c) offering. Our marketing and investor outreach efforts are in full swing — and the results are exciting. ✨ We’ve already connected with 5,250 family offices, fund managers, and top-tier investment firms through our targeted campaign. 📞 31 investor calls completed 📝 47 applications processed 📂 22 additional investment applications currently under documentation review and updates We’re steadily expanding our reach, building high-value investment relationships, and positioning CSDX for its next major phase of growth. More updates coming soon — stay tuned! $CSDX #RegD #Investment #PrivateOffering

🚀 🚀 Big Momentum at $CSDX! Our latest 10-Q for the period ended September 30th 2025 has been filed. Snapshot shows powerful progress: • 📈 189% revenue growth in the most recent period • 🔧 Liabilities remain extremely low • 🧭 Continued improvement in retained earnings We’re building, scaling, and delivering—one milestone at a time. Onward and upward! Towards our consolidation of our Annual Reports 2025 🚀✨ $CSDX

CSDX is taking needful measures to consolidate CS Group financials according to the roadmap steps for NASDAQ uplisting $CSDX accessnewswire.com/newsroom/…

We are pleased to announce a strong start to our Regulation D, Rule 506(c) Offering. In just the first week, we have already received 17 investment applications from accredited investors. Which reflects the market’s confidence in our mission, our products, and our long-term growth strategy. Stay tuned — weekly Reg D progress updates will follow. $CSDX #RegD #InvestorUpdate

The wait is over!! Our Regulation D, Rule 506(c), Private Placement offering is officially live. A new era of growth, healthcare innovation, and opportunity begins — with CS Diagnostics Corp at the forefront. Be part of the future. accessnewswire.com/newsroom/… #CSDX #CSCorp #RegD #InvestWithUs #Healthcare #Innovation #GlobalGrowth